GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
LGLIX
Price
$57.57
Change
-$1.90 (-3.19%)
Updated
Nov 13 closing price
Net Assets
8.01B
Interact to see
Advertisement

GFACX vs LGLIX

Header iconGFACX vs LGLIX Comparison
Open Charts GFACX vs LGLIXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
Lord Abbett Growth Leaders I
Price$57.57
Change-$1.90 (-3.19%)
VolumeN/A
Net Assets8.01B
GFACX vs LGLIX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. LGLIX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and LGLIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. LGLIX (8.01B). GFACX (0.00) and LGLIX (0.00) have matching dividends . GFACX was incepted earlier than LGLIX: GFACX (25 years) vs LGLIX (14 years). GFACX (1.36) is less costly to investors than LGLIX (0.65). LGLIX is a more actively managed with annual turnover of: 94.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than LGLIX: GFACX (250) vs LGLIX (1000000). LGLIX annual gain was more profitable for investors over the last year : 16.05 vs. GFACX (4.61). GFACX return over 5 years is better than : 27.87 vs. LGLIX (25.04).
GFACXLGLIXGFACX / LGLIX
Total Expense Ratio1.360.65209%
Annual Report Gross Expense Ratio1.360.65209%
Fund Existence25 years14 years-
Gain YTD16.34315.882103%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets340B8.01B4,245%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.6116.0529%
Returns for 3 years56.17111.1151%
Returns for 5 years27.8725.04111%
Returns for 10 years75.78144.6752%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics